PATENT CLAIM ANALYSIS

Application Number: 16033632
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["544", "298000"]

Abstract:
Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.

Claim (Index 21):
A kit, the kit comprising: the compound of  claim 1  or the pharmaceutically acceptable salt thereof and at least one additional therapeutic agent selected from an \u03b1-blocker, a \u03b2-blocker, an angiotensin converting enzyme (ACE) inhibitor, an angiotensin-receptor blocker (ARB), a calcium channel blocker, a diuretic, an inhibitor of the funny current, a myosin activator, or a neutral endopeptidase (NEP) inhibitor.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 95.0
- Lexical Diversity: 1.64865
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15298686', '15298434', '15297487', '15945852', '15297272']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8675196528158342
- 35 USC 102 Novelty (BERT): 0.6959334550241784
- Combined Prediction Score: 0.8503610330366687
- Mean Citation Score: 707.229046
- Max Citation Score: 724.00323
- Similarity Product: 710.065192888341

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test